Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model.

by Tzong-Tyng Hung, Jeffrey Chan, Pamela J Russell, Carl A Power
Published 2011-01-01

Combination therapy with the histone deacetylase inhibitor LBH589 and radiation is an effective regimen for prostate cancer cells.

by Weiwei Xiao, Peter H Graham, Jingli Hao, Lei Chang, Jie Ni, Carl A Power, Qihan Dong, John H Kearsley, Yong Li
Published 2013-01-01

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147.

by Jingli Hao, Michele C Madigan, Aparajita Khatri, Carl A Power, Tzong-Tyng Hung, Julia Beretov, Lei Chang, Weiwei Xiao, Paul J Cozzi, Peter H Graham, John H Kearsley, Yong Li
Published 2012-01-01

A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone

by Laure Thibaudeau, Anna V. Taubenberger, Boris M. Holzapfel, Verena M. Quent, Tobias Fuehrmann, Parisa Hesami, Toby D. Brown, Paul D. Dalton, Carl A. Power, Brett G. Hollier, Dietmar W. Hutmacher
Published 2014-02-01